Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is attracting investor attention with its ambitious pipeline and a staggering potential upside of 404.04% based on current analyst price targets. Specializing..
Oculis Holding AG (NASDAQ: OCS) is capturing the attention of investors with its promising pipeline in the biotechnology sector, especially in ophthalmology. Based in Zug, Switzerland, this clinical-stage biopharmaceutical company..
HealthStream, Inc. (NASDAQ: HSTM), a notable player in the Health Information Services industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With its SaaS-based applications, HealthStream..
Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector specializing in diagnostics and research, presents a fascinating case for investors with its substantial potential upside of 70.76%...
Cross Country Healthcare, Inc. (NASDAQ: CCRN) is a noteworthy player in the healthcare staffing industry, providing essential talent management services across the United States. Catering to a broad spectrum of..
Immunome, Inc. (NASDAQ: IMNM), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its innovative approaches in oncology therapeutics and a promising stock valuation outlook...
Ardelyx, Inc. (ARDX), a biotechnology firm headquartered in Waltham, Massachusetts, is capturing investor attention with its promising pipeline and compelling stock potential. Operating within the healthcare sector, Ardelyx focuses on..
Delcath Systems, Inc. (DCTH) is making waves in the healthcare sector, particularly within the medical device industry, with its innovative approach to cancer treatment. As an interventional oncology company, Delcath..
Investors seeking opportunities in the healthcare sector should closely examine Talkspace, Inc. (NASDAQ: TALK), a virtual behavioral healthcare provider with an intriguing growth story and notable market potential. Specializing in..
Definitive Healthcare Corp. (NASDAQ: DH) stands as a notable entity within the healthcare sector, specifically in the health information services industry. Founded in 2011 and headquartered in Framingham, Massachusetts, the..
Sana Biotechnology, Inc. (NASDAQ: SANA), a burgeoning player in the healthcare sector, is making waves in the biotechnology industry with its ambitious approach to cell-based therapies. Headquartered in Seattle, Washington,..
Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector with its innovative approach to ultrasound imaging solutions. As a player in the medical devices industry, Butterfly Network..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is capturing attention in the healthcare sector with its focus on specialty pharmaceuticals, particularly in the domain of pain management. With a market capitalization of..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is making waves in the biotechnology sector with its pioneering approach to treating hereditary angioedema (HAE), a rare and potentially life-threatening genetic condition. This Massachusetts-based..
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is capturing investor attention with its promising pipeline of gene therapies targeting monogenic diseases of the central nervous system. The clinical-stage biotechnology firm, headquartered..
Relay Therapeutics, Inc. (NASDAQ: RLAY) is capturing the attention of investors with its compelling growth potential within the biotechnology sector. With a market capitalization of $1.72 billion, this clinical-stage precision..
Geron Corporation (NASDAQ: GERN), a commercial-stage biopharmaceutical firm based in Foster City, California, has captured the attention of investors with its ambitious product pipeline and significant potential upside. Specializing in..
Pharvaris N.V. (PHVS) is capturing the attention of investors with its promising potential upside in the competitive biotechnology sector. With a market capitalization of $1.68 billion, this Switzerland-based company is..
Zenas BioPharma, Inc. (ZBIO), a promising player in the biotechnology industry, has been catching the eye of investors with its innovative approach to immunology-based therapies. Headquartered in Waltham, Massachusetts, this..
